Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Cytarabine × 90 days × Clear all

Phase

Phase 2 45 Phase 1 24 Phase 3 16 Phase 1/2 8 Phase 2/3 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

pembrolizumab 7 Specimen Handling 6 Radiotherapy 5 Nivolumab 5 Magnetic Resonance Spectroscopy 5 Dexamethasone 4 Biopsy 4 Bevacizumab 4 encorafenib 3 X-Rays 3 Tirzepatide 3 Radiation 3 Immunotherapy, Adoptive 3 Immunoglobulin G 3 Folfox protocol 3 Disulfides 3 Cyclophosphamide 3 Cisplatin 3 venetoclax 2 tremelimumab 2 tislelizumab 2 olaparib 2 niraparib 2 fludarabine 2 binimetinib 2 Watchful Waiting 2 Vaccines 2 Simvastatin 2 Rituximab 2 Panitumumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03568994 2026-01-27

ATACC AML

Baylor College of Medicine

Phase EARLY_PHASE1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡